Anixa Biosciences (ANIX) Stock Chart & Stock Price History → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free ANIX Stock Alerts $2.94 -0.03 (-1.01%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Anixa Biosciences Stock Price Performance5 Day Performance-2.65%1 Month Performance-6.37%3 Month Performance-36.09%6 Month Performance-8.70%Year-To-Date Performance-24.23%1 Year Performance-26.32% Receive ANIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. ANIX Stock Chart for Saturday, May, 4, 2024 ANIX Chart by TradingView Anixa Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$2.97$2.94-1.01%$3.06$2.85115,773 shs$93.79 million05/02/2024$3.09$2.97-3.88%$3.10$2.9751,980 shs$94.74 million05/01/2024$2.97$3.09+4.04%$3.15$2.9858,633 shs$98.57 million04/30/2024$3.02$2.97-1.66%$3.09$2.92110,023 shs$94.74 million04/29/2024$3.23$3.02-6.50%$3.25$3.02157,786 shs$96.34 million04/26/2024$2.98$3.23+8.39%$3.32$3.13232,647 shs$103.04 million Get the Latest News and Ratings for ANIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$3.18$2.98-6.29%$3.32$2.94250,178 shs$95.06 million04/24/2024$3.07$3.18+3.58%$3.40$3.04356,961 shs$101.44 million04/23/2024$3.01$3.07+1.99%$3.12$3.0073,264 shs$97.93 million04/22/2024$3.12$3.01-3.53%$3.16$3.0157,975 shs$96.02 million04/19/2024$3.10$3.12+0.65%$3.20$3.0532,692 shs$99.53 million04/18/2024$3.05$3.10+1.64%$3.12$3.0358,502 shs$98.89 million04/17/2024$3.17$3.05-3.79%$3.20$3.0572,904 shs$97.30 million04/16/2024$3.16$3.17+0.32%$3.25$3.1678,203 shs$101.12 million04/15/2024$3.17$3.16-0.32%$3.24$3.1599,028 shs$100.80 million04/12/2024$3.22$3.17-1.55%$3.23$3.1750,947 shs$101.12 million04/11/2024$3.20$3.22+0.63%$3.25$3.2033,524 shs$102.72 million04/10/2024$3.25$3.20-1.54%$3.42$3.1760,191 shs$102.08 million04/09/2024$3.17$3.25+2.52%$3.35$3.1752,858 shs$103.68 million04/08/2024$3.20$3.17-0.94%$3.21$3.1240,735 shs$101.12 million04/05/2024$3.14$3.20+1.91%$3.26$3.09100,471 shs$102.08 million04/04/2024$3.28$3.14-4.27%$3.31$3.0961,950 shs$100.17 million04/03/2024$3.20$3.28+2.50%$3.29$3.1092,723 shs$104.63 million04/02/2024$3.35$3.20-4.48%$3.34$3.1643,067 shs$102.08 million04/01/2024$3.12$3.35+7.37%$3.48$3.06182,640 shs$106.87 million03/29/2024$3.12$3.12$3.39$3.08123,508 shs$99.53 million03/28/2024$3.23$3.12-3.41%$3.39$3.08123,508 shs$99.53 million03/27/2024$3.13$3.23+3.19%$3.30$3.1352,698 shs$103.04 million03/26/2024$3.23$3.13-3.10%$3.25$3.0867,066 shs$99.85 million03/25/2024$3.46$3.23-6.65%$3.48$3.14128,668 shs$103.04 million03/22/2024$3.69$3.46-6.23%$3.68$3.29138,016 shs$110.37 million03/21/2024$3.73$3.69-1.07%$3.84$3.60107,456 shs$117.71 million03/20/2024$3.60$3.73+3.61%$4.10$3.65420,451 shs$118.99 million03/19/2024$3.51$3.60+2.56%$3.75$3.37245,690 shs$114.84 million03/18/2024$3.69$3.51-4.88%$3.80$3.51100,761 shs$111.97 million03/15/2024$3.08$3.69+19.81%$3.74$3.07343,405 shs$117.71 million03/14/2024$3.18$3.08-3.14%$3.21$3.0191,361 shs$97.67 million03/13/2024$3.08$3.18+3.25%$3.22$3.13114,851 shs$100.84 million03/12/2024$3.23$3.08-4.64%$3.34$3.08132,528 shs$97.67 million03/11/2024$3.25$3.23-0.62%$3.28$3.10154,869 shs$102.42 millionInvestors Alert: The Next Big Thing in Weight Loss (Ad)UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> 03/08/2024$3.45$3.25-5.80%$3.56$3.21225,417 shs$103.06 million03/07/2024$3.50$3.45-1.43%$3.52$3.4198,187 shs$109.40 million03/06/2024$3.56$3.50-1.69%$3.67$3.44101,515 shs$110.99 million03/05/2024$3.72$3.56-4.30%$3.80$3.53114,691 shs$112.89 million03/04/2024$3.51$3.72+5.98%$3.80$3.51146,013 shs$117.96 million03/01/2024$3.50$3.51+0.29%$3.62$3.4962,740 shs$111.30 million02/29/2024$3.51$3.50-0.28%$3.62$3.4953,316 shs$110.99 million02/28/2024$3.55$3.51-1.13%$3.63$3.4772,133 shs$111.30 million02/27/2024$3.44$3.55+3.20%$3.62$3.4671,092 shs$112.57 million02/26/2024$3.59$3.44-4.18%$3.67$3.39118,625 shs$109.08 million02/23/2024$3.56$3.59+0.84%$3.70$3.5075,680 shs$113.84 million02/22/2024$3.77$3.56-5.57%$3.81$3.53129,621 shs$112.89 million02/21/2024$3.86$3.77-2.33%$3.91$3.64138,949 shs$119.55 million02/20/2024$4.05$3.86-4.69%$4.09$3.81220,176 shs$122.40 million02/19/2024$4.05$4.05$4.30$3.98132,700 shs$128.43 million02/16/2024$4.08$4.05-0.74%$4.30$3.98132,708 shs$128.43 million02/15/2024$4.28$4.08-4.67%$4.35$4.00179,273 shs$129.39 million02/14/2024$4.30$4.28-0.47%$4.46$4.13255,336 shs$135.73 million02/13/2024$4.46$4.30-3.59%$4.50$4.2276,107 shs$136.35 million02/12/2024$4.51$4.46-1.11%$4.67$4.42137,285 shs$141.43 million02/09/2024$4.48$4.51+0.67%$4.66$4.48111,166 shs$142.02 million02/08/2024$4.46$4.48+0.45%$4.54$4.30102,499 shs$142.02 million02/07/2024$4.64$4.46-3.88%$4.65$4.4681,576 shs$141.38 million02/06/2024$4.55$4.64+1.98%$4.65$4.4848,101 shs$147.09 million02/05/2024$4.60$4.55-1.09%$4.62$4.45143,614 shs$144.24 million Related Companies: Clearside Biomedical Stock Price Chart Oramed Pharmaceuticals Stock Price Chart BioXcel Therapeutics Stock Price Chart IO Biotech Stock Price Chart Allakos Stock Price Chart PMV Pharmaceuticals Stock Price Chart OptiNose Stock Price Chart Cue Biopharma Stock Price Chart DiaMedica Therapeutics Stock Price Chart Emergent BioSolutions Stock Price Chart Receive ANIX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANIX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.